{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:58:58Z","timestamp":1778551138662,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["MUR ex DM 1059\/2021"],"award-info":[{"award-number":["MUR ex DM 1059\/2021"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004770","name":"Universit\u00e0 degli Studi di Parma","doi-asserted-by":"publisher","award":["COVID-19\u20142020"],"award-info":[{"award-number":["COVID-19\u20142020"]}],"id":[{"id":"10.13039\/501100004770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejps.2023.106609","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T02:28:15Z","timestamp":1697164095000},"page":"106609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide"],"prefix":"10.1016","volume":"191","author":[{"given":"Stefania","family":"Glieca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Cavazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Levati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Garrapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Bolchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Odau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Ottonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Donofrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"F\u00fcner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Sonvico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruggero","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Montanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-4823","authenticated-orcid":false,"given":"Francesca","family":"Buttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106609_bib0001","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.drudis.2021.04.009","article-title":"Leucine as an excipient in spray dried powder for inhalation","volume":"26","author":"Alhajj","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejps.2023.106609_bib0002","first-page":"79","article-title":"Immunopathogenesis of pneumonia in covid-19","volume":"19","author":"Alipoor","year":"2020","journal-title":"Tanaffos"},{"issue":"10","key":"10.1016\/j.ejps.2023.106609_bib0003","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s13346-023-01346-3","article-title":"Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin","volume":"13","author":"Bianchera","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2023.106609_bib0004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jamp.2022.0020","article-title":"Stability and activity of interferon beta to treat idiopathic pulmonary fibrosis with different nebulizer technologies","volume":"36","author":"Brun","year":"2023","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"issue":"11","key":"10.1016\/j.ejps.2023.106609_bib0005","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.3390\/pharmaceutics13111936","article-title":"Understanding the importance of capsules in dry powder inhalers","volume":"13","author":"Buttini","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106609_bib0006","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.abd9909","article-title":"De novo design of picomolar SARS-CoV-2 miniprotein inhibitors","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ejps.2023.106609_bib0007","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.chom.2021.06.008","article-title":"Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice","volume":"29","author":"Case","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejps.2023.106609_bib0008","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.addr.2021.02.017","article-title":"Dry powder pharmaceutical biologics for inhalation therapy","volume":"172","author":"Chang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106609_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.addr.2021.02.016","article-title":"Pharmaceutical protein solids: drying technology, solid-state characterization and stability","volume":"172","author":"Chen","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106609_bib0010","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/js9800679","article-title":"Effect of mannitol crystallization on the stability and aerosol performance of a spray-dried pharmaceutical protein, recombinant humanized anti-IgE monoclonal antibody","volume":"87","author":"Costantino","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106609_bib0011","article-title":"A simplified SARS-CoV-2 pseudovirus neutralization assay","volume":"9(4), 389","author":"Donofrio","year":"2021","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.ejps.2023.106609_bib0012","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1208\/s12249-021-02043-5","article-title":"Spray-dried inhalable powder formulations of therapeutic proteins and peptides","volume":"22","author":"Eedara","year":"2021","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejps.2023.106609_bib0013","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2174\/1381612822666160210142910","article-title":"Inhaled biologics: from preclinical to product approval","volume":"22","author":"Fathe","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2023.106609_bib0014","first-page":"139","article-title":"Large porous hollow particles: lightweight champions of pulmonary drug delivery","volume":"176","author":"Gharse","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejps.2023.106609_bib0015","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41565-022-01174-5","article-title":"Nanotechnology-based strategies against SARS-CoV-2 variants","volume":"17","author":"Huang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejps.2023.106609_bib0016","first-page":"eabn1252","article-title":"Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice","volume":"14 (646)","author":"Hunt","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejps.2023.106609_bib0017","series-title":"Encyclopedia of Pharmaceutical Science and Technology","first-page":"2607","article-title":"Peptides and proteins: pulmonary absorption","author":"Koussoroplis","year":"2013"},{"key":"10.1016\/j.ejps.2023.106609_bib0018","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/164_2019_335","article-title":"100 years of drug delivery to the lungs","volume":"260","author":"Lavorini","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106609_bib0019","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3201\/eid2607.200718","article-title":"Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster, Xuzhou, China","volume":"26","author":"Li","year":"2020","journal-title":"Emerg. Infect. Dis. J."},{"issue":"1","key":"10.1016\/j.ejps.2023.106609_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1208\/s12248-020-00532-2","article-title":"Recent developments on therapeutic and diagnostic approaches for COVID-19","volume":"23","author":"Majumder","year":"2021","journal-title":"AAPS J"},{"issue":"1979","key":"10.1016\/j.ejps.2023.106609_bib0021","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.abl8506","article-title":"Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants","volume":"374","author":"McCallum","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejps.2023.106609_bib0022","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s11095-022-03318-7","article-title":"Effect of buffer salts on physical stability of lyophilized and spray-dried protein formulations containing bovine serum albumin and trehalose","volume":"40","author":"Mutukuri","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106609_bib0023","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/07373937.2021.1903032","article-title":"Progress in spray-drying of protein pharmaceuticals: literature analysis of trends in formulation and process attributes","volume":"39","author":"Pinto","year":"2021","journal-title":"Dry. Technol."},{"key":"10.1016\/j.ejps.2023.106609_bib0024","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jconrel.2020.04.015","article-title":"Excipient-free pulmonary insulin dry powder: pharmacokinetic and pharmacodynamics profiles in rats","volume":"323","author":"Quarta","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106609_bib0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2017.10.024","article-title":"Nebulized coenzyme Q(10) nanosuspensions: a versatile approach for pulmonary antioxidant therapy","volume":"113","author":"Rossi","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106609_bib0026","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2021.11.002","article-title":"A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant","volume":"340","author":"Rossi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106609_bib0027","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejps.2023.106609_bib0028","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106609_bib0029","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41423-022-00884-z","article-title":"Jigsaw puzzle of SARS-CoV-2 RBD evolution and immune escape","volume":"19","author":"Yi","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejps.2023.106609_bib0030","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/S2666-5247(23)00011-3","article-title":"Advances in developing ACE2 derivatives against SARS-CoV-2","volume":"4","author":"Zhang","year":"2023","journal-title":"Lancet Microbe"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:10:49Z","timestamp":1760530249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"alternative-id":["S0928098723002397"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106609","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106609"}}